Androski Lindsay 4
4 · Eloxx Pharmaceuticals, Inc. · Filed Jul 6, 2022
Insider Transaction Report
Form 4
Androski Lindsay
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-07-01+40,000→ 40,000 totalExercise: $0.25Exp: 2032-07-01→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 50% of the underlying shares on July 1, 2023 and the remainder in twelve (12) equal monthly installments thereafter.